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Abstract 
Objective Patients with vascular cognitive impairment (VCI) are a very heterogeneous group 
based on their clinical presentation and their pathology. Differences in neurocognition within 
the group of VCI patients have not yet been investigated. To be diagnosed with VCI, brain 
imaging, neuropsychological examination and clinical presentation are of particular 
importance. This study aims to investigate what the first cognitive symptoms of VCI patients 
are and if we can objectify the differences and similarities in neuropsychological performance 
between the most frequent symptom groups. Furthermore, we aim to investigate what the 
most frequent combinations of cerebrovascular disease (CVD, i.e. white matter lesions, 
microbleeds, lacunes, infarctions and haemorrhages) are and their contribution to cognition.  
Methods 181 VCI patients were selected from the Amsterdam Dementia Cohort and the first 
cognitive symptoms were retrieved and quantified. Patients were divided into most prominent 
memory problems, frontal dysfunction or others. These groups were compared on 
neuropsychological features using an analysis of variance. Z-scores have been generated to 
determine domain scores and to compare neuropsychological tests scores. A Two-Step cluster 
analysis was used to detect frequent combinations of CVD. When necessary, these clusters 
were compared on clinical and neuropsychological features using an analysis of variance or 
multinominal logistic regression. 
Results Memory problems were the most frequent symptom, followed by change of behavior. 
Executive dysfunction was found in 5,5% of the VCI patients. Patients with memory 
problems, frontal dysfunction and other cognitive problems differed in performance on the 
domain of memory and language. Patients with severe CVD had the lowest scores on all tests, 
in particular the immediate and delayed recall of the Rey Auditory Verbal Learning Task. 
Conclusion This study indicates that within the group of VCI patients, different 
neuropsychological profiles exist. If worked out further, these profiles might in the future be 
used to detect patients earlier and to choose the appropriate intervention.  
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Introduction 
 
Dementia places a major burden on global health care. The prevalence of dementia has been 
estimated to increase substantially from 7.1 million cases in 2000 to 16.3 million cases in 
2050 worldwide (Dichgans, & Zietemann, 2012; Luck, Luppa, & Riedel-Heller, 2012). 
 
Dementia is a clinical syndrome characterized by decline of cognitive functions and change of 
behaviour, causing impairment in daily life. Dementia is caused by a brain disease. In almost 
50% of the cases the dementia is due to Alzheimer’s disease (AD). The second most common 
form of dementia is vascular dementia (VaD). In VaD at least one cognitive domain is 
affected and there should be a temporal relationship with cerebrovascular disease (CVD).  
 
Historically, definitions such as VaD or ‘multiinfarct dementia’ (MID) were used to describe 
dementia caused by vascular disease. However, these definitions only reflect the extreme ends 
of a spectrum of cognitive impairment and do not include the prodromal stage (Hachinski et 
al., 2006). For that reason, the term ‘vascular cognitive impairment’ (VCI) was introduced. 
The term VCI is used as an umbrella term to explain all forms of cognitive dysfunction 
caused by cerebrovascular disease ranging from mild impairment, called vascular mild 
cognitive impairment (vaMCI), to overt vascular dementia (Black, 2010; Gorelick, 2011; 
Dichtgans, & Zietemann, 2012; Rincon, & Wright, 2013; Selnes, & Vinters, 2006; Young 
Lee, 2006). In vaMCI the cognitive symptoms can affect one or multiple cognitive domains, 
but are limited. Patients with vaMCI have no significant interference in their daily life 
activities. However, vaMCI patients do have an increased risk for developing (vascular) 
dementia.  
 
VCI defines a very heterogeneous group of patients due to various manifestations of vascular 
brain injury, which may contribute to cognitive decline. These manifestations of vascular 
brain injury include silent brain infarcts
1
(lacunes), white matter lesions and overt strokes 
(Gorelick et al., 2011). VCI can be present in its pure form, but is also often seen in 
combination with Alzheimer’s disease (Neuropathology Group. MRC-FAS, 2001; Prins et al., 
2004). 
                                                     
1
 An infarct (dead tissue) is caused either by thrombosis or embolism resulting in dead tissue. Infarcts 
are dificed into two categories: hemorrhagic and ischemic infarcts. Ischemic infarcts are caused 
because a thrombus or embolus cuts off the blood supply to the brain. Hemorrhagic infracts are 
associated with embolisms and a brain hemmorhage is present. Stroke is the clinical term for 
symptoms that arise from cerebrovascular events.  
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In the diagnostic process of VCI, neuroimaging, clinical presentation and neuropsychological 
examination are especially important. In order to be diagnosed with VCI, there must be 
evident CVD on brain imaging and cognitive decline which interferes with activities of daily 
living which are not due to physical effects of stroke alone. Cognitive decline is assessed 
through an (hetro)anamnestic interview and neuropsychological tests (Albert et al., 2011; 
Román et al., 1993).  
 
Magnetic resonance imaging (MRI) and other neuroimaging techniques play an important role 
in the detection of VCI. MRI studies provide evidence that deep infarcts and white matter 
lesions are common in VCI (Gorelick et al., 2011). Numerous studies have examined 
relationships between vascular disease on MRI and cognitive ability. Most studies suggest 
that vascular disease is associated with non-memory-related cognitive deficits (Gunning-
Dixon, & Raz, 2000). On the contrary, a number of studies do show similar associations with 
memory impairment.  
 
Several studies focused on discriminating VCI patients from other types of dementia (mainly 
AD), based on their neuropsychological test performance. These studies revealed that it is 
hard to discriminate between VCI and AD, because cognitive symptoms overlap. However 
other neuropsychological studies show that AD patients tend to be more impaired on the 
domain of episodic memory compared to VCI patients. Whereas VCI patients perform worse 
on tests of executive functions, including planning and sequencing, speed of mental 
processing and attention, compared to AD patients (Desmond, 2004). Although primary 
language tend to be preserved, language production may also be impaired in VCI patients 
(Weintraub, Wicklund, & Salmon, 2012).  
 
Some studies tried to associate different types of vascular disease with neuropsychological 
test scores. For example, white matter hyperintensities have been associated with lower scores 
on the mini mental state examination (MMSE). However, the findings are rather inconsistent 
and do not focus on specific cognitive domains (Gorelick et al., 2011). Other studies revealed 
that VCI patients have a distinct neuropsychological profile. VCI patients show deficits in 
executive and attentional abilities. Furthermore, impairment in semantic memory and 
perceptual function was found (Graham, Emery, & Hodges, 2014). Another study found that 
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VCI patients are predominantly impaired on executive function, verbal memory and non-
verbal memory (Reed et al., 2007).  
 
Studies mentioned above showed varying results for VCI patients on neuropsychological 
testing. However within patients with VCI, a large inter-patient variability exists, i.e. the 
presence and extent of executive dysfunction and memory impairment varies between 
patients. As a consequence, patients have various presentations in the clinic (Weintraub, 
Wicklund, & Salmon, 2012). Besides cognitive decline, patients with VCI frequently suffer 
from mood disturbances, behavioural change, and impaired motor function (Bowler et al., 
2009; Gorelick et al., 2005). 
 
Taken together, VCI patients form a heterogeneous group regarding pathology on brain 
imaging and also on clinical presentation concerning their cognitive symptoms. To our 
knowledge, there are no studies investigating the differences in neuropsychological test 
performance within VCI patients. So, despite the large heterogeneous appearance of VCI 
patients at this moment they are all described by one covering neuropsychological profile. 
This profile consist of memory problems and executive problems (Graham, Emery, & 
Hodges, 2014; Reed et al., 2007).  
 
Ideally, VCI patients should be better recognized to improve diagnosis and therefore select 
the right treatment and care. In order to accomplish this, we first need to know what defines 
the VCI patient. And if then possible to define distinct subgroups within the group of VCI 
patients.  
 
Because of the earlier described inter-patient variability, our first aim is to explore the 
prominent cognitive symptoms of VCI patients at their first presentation in our memory clinic 
(i.e. the Amsterdam Dementia Cohort). Studies investigating the symptom awareness of 
patients with mild  cognitive impairment (MCI) or Alzheimer’s disease show impaired 
awareness of their symptoms (Vogel et al., 2004). This impaired awareness can result in a less 
accurate reportage of symptoms. For example; not knowing how to cook anymore can be 
caused by loss of overview due to executive dysfunction or forgetting how to cook due to 
memory problems.  So patients may report memory problems while the underlying cognitive 
deficit may be executive dysfunction. This means that the subjective complaints can be 
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different from the objective disturbed domain on neuropsychological tests causing 
misdiagnosis. Also awareness is significantly related to the severity of dementia of any type, 
including vascular dementia (Verhey, Rozendaal, Ponds, & Jolles, 2004). So more severely 
demented patients are less aware of their symptoms. This then results in a less accurate self 
reportage of their symptoms. Therefore, we want to objectify our findings by investigating 
whether there are differences between the anamnestic cognitive symptoms and 
neuropsychological test scores by establishing neurocognitive profiles scores based on these 
cognitive symptoms.  
 
Last, we will investigate whether CVD measures on MRI (i.e. white matter hyperintensities, 
lacunes, microbleeds, infarcts and haemorrhages) do correlate with the prominent subjective 
symptoms and neuropsychological test performance. Patients often have combinations of 
vascular damage, for example an infarct and several microbleeds (Hoon Roh, & Lee, 2014). 
For that reason, the CVD measures will not be investigated as a separate entity, but will be 
clustered in frequently occurring combinations of CVD.  
 
Research Questions and Hypotheses (H) 
 
The following research questions have been established: 
 
1. What are the first cognitive symptoms for VCI patients?  
H: The most prominent first cognitive symptoms are memory problems and 
executive dysfunction. 
2. Can we objectify the first cognitive symptoms in VCI patients with performance on 
neuropsychological tests?  
H: First cognitive symptoms in VCI patients can be objectified with 
performance on neuropsychological tests.  
3. What are frequent combinations of CVD in VCI patients and what is the contribution 
of these CVD combinations on cognition?  
H: Patients with more and more severe CVD will be more impaired on NPO 
scores, especially non-memory-related cognitive functions. 
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 Methods 
 
Design 
 
For the current study a retrospective cross-sectional observational study design was used. 
 
Sample 
 
Amsterdam Dementia Cohort 
The subjects for the current study are patients from the Amsterdam Dementia Cohort. The 
Amsterdam Dementia Cohort is a database with well over 4000 patients who visited the 
Alzheimer Center of the VU University Medical Center (VUmc) between 1998 and 2014. 
Patients were referred to the clinic for a dementia screening or second opinion when 
diagnosed with dementia. 70% of the patients have an early onset of symptoms (<70 years of 
age).  
 
The diagnostic procedure is organized in such a way, that each patient who visited the 
Alzheimer Center underwent all necessary examinations in one day. The same diagnostic 
work-up was used for each patient: structured interview, medical and neurological 
investigation by a neurologist, brain magnetic resonance imaging (MRI), 
electroencephalogram (EEG), lumbar puncture, blood sample investigation and 
neuropsychological investigation (NPO). The standardized NPO test battery has been 
previously described by van der Flier et al. (2014). When necessary, the heteroanamnese was 
acquired by phone.  
 
Clinical diagnoses were made according to current clinical criteria in a multidisciplinary 
assessment. For the diagnosis of VCI, NINDS-AIREN criteria (Román et al., 1993) and the 
National Institute on Aging-Alzheimer’s Association (NIA-AA) criteria were used (Appendix 
I and II) (Albert et al., 2011).  
 
The protocol for the use of clinical data for research purposes was approved by the medical 
ethical committee of the VUmc. All patients gave written informed consent for the use of 
their clinical data for research purposes (Appendix III).  
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Study sample 
 
For the current study, initially 287 patients were selected from this database. Inclusion 
criterium was the diagnosis of VCI (probable or possible VaD or probable or possible 
vaMCI). Because complete case analysis (exclusion of all patients with one or more missing 
data on the neuropsychological tests) often results in loss of statistical power, we only 
excluded patients if there was missing data on MRI or missing data on one entire 
neuropsychological domain, i.e. missing data on all tests for memory, executive function, 
attention etc. (Figure 1). VCI patients are known to have comorbidity with psychiatric 
diseases such as depression (Winter, Korchounov, Zhukova, & Bertschi, 2011). Therefore, 
patients with psychiatric comorbidity were not excluded. Instead two tests measuring 
psychiatric symptoms were used as covariates, i.e. the Geriatric Depression Scale (GDS) and 
the Neuropsychiatric Inventory (NPI).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Flow chart of study participants  
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Measures and procedures 
 
The most prominent cognitive symptoms of VCI patients at their first presentation in our 
memory clinic were not yet systematically noted in the Amsterdam Dementia Cohort 
database. Therefore, we investigated patient files for first symptoms in the electronic patients 
records database and when necessary in the hardcopy patient records. The most prominent 
(hetero)anamnestic cognitive symptoms at first presentation were listed and divided into the 
following cognitive domains: memory (short and long term memory problems), executive 
functioning (problems with working memory, planning and cognitive flexibility), visuo-
spatial (problems with orientation in space), attention (problems with concentration, attention 
and constraints in capacity of information processing), change of behaviour (including 
apathy) and language (aphasia, problems in speech and language). In case of multiple 
symptoms were noted, we investigated the referral letters for the most prominent complaint. 
When more clarity was necessary, in cases with multiple complaints, a neurologist was 
consulted. Last a group named ‘others’ was used for all patients with other problems than 
described in de previous clusters.  
For the statistical analyses, the cognitive symptoms were divided into the following clusters: 
memory, frontal dysfunction (i.e. executive problems, attention and change of behaviour) and 
others (including visuo-spatial problems and language).  
 
Neuropsychological measures 
 
Global cognition 
To indicate global cognitive decline data from the Mini-Mental State Examination (MMSE) 
was used (Cronbach’s α= 0.68-0.96, sensitivity=100%, specificity=100% (Tombaugh, & 
McIntyre, 1992)). MMSE is a short examination of cognitive functioning with a total of 30 
points. Seven domains can be distinguished: orientation in time (5 points), spatial orientation 
(5 points), registering of words (3 points), concentration and calculating (5 points), 
remembering of words (3 points), language (8 points) and visual perception (1 point). The 
cut-off score for dementia is 24. 
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Memory  
For assessment of the memory domains we used the data of two memory tasks; the Visual 
Association Test (VAT) and the Dutch version of the Rey auditory verbal learning task 
(RAVLT). The VAT was used to examine visual memory (Cronbach’s α= 0.88, 
sensitivity=87.5%, specificity=97.5% (Lindeboom, Schmand, Tulner, Walstra, & Jonker, 
2002)). In this test six figures are shown and the patient is asked to name these figures (trail 
1). After a certain time delay the patient is asked what he/she remembers (trail 2). The number 
of figures remembered were noted with a higher score indicating a better performance 
 
For verbal memory we used to examine memory encoding, storage and retrieval, the 
immediate and delayed recall of the Dutch version of the Rey auditory verbal learning task 
(Cronbach’s α= 0.70, sensitivity=75.7%, specificity=91.5% (Boone, Lu, & Wen, 2004; Snow, 
1988)). A list of 15 words was read to the patient five times and the patient was asked which 
words he/she remembered immediately after the list was read and again after a ten-minute 
delay. Cut-off scores were determined based on age and educational background. For both the 
immediate and the delayed recall the score is the number of words remembered. A higher 
score indicates a better performance.  
 
Language 
To examine language skills we used the data of the VAT and the Dutch version of Controlled 
Oral Word Association Test (letter fluency, DAT). The patient is asked to name as many 
words as they know beginning with the letter D, A, or T (Schmand, Groenink, & van den 
Dungen, 2008). The total number of words for the three letters were noted. A higher score 
indicates a better performance. Cut-off scores were determined based on age and educational 
background. 
 
Attention  
To examine attention we used the data of the forward condition of Digit Span (Cronbach’s α= 
0.81 (Kalbe et al., 2004)) and Trail Making Test A (TMT-A) (Cronbach’s α= 0.84, 
sensitivity=61.9%, specificity=70.3% (Ashendorf et al., 2008)). In the TMT-A twenty-five 
circles with numbers need to be connected in a chronological order. The time needed to 
complete the task  was noted in seconds. A higher score indicates a worse performance.  In 
the digit span forward the patients were asked to repeat the numbers in the correct order. The 
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maximum span that was achieved was noted. A higher span means a better performance.Cut-
off scores were determined based on age and educational background. 
 
Executive function 
Executive function and focused attention was assessed with the data of the TMT-B 
(Cronbach’s α= 0.84, sensitivity=61.9%, specificity=70.3% (Ashendorf et al., 2008)). In the 
TMT-B circles with numbers and letters needs to be connected in chronological order while 
changing between numbers and letters, 1-A-2-B-3-C etc. The time needed to complete the 
task  was noted in seconds. A higher score indicates a worse performance. Furthermore, 
executive function was also tested with the backward condition of Digit Span (Cronbach’s α= 
0.81 (Kalbe et al., 2004)). In the digit span backward patients were asked to repeat the 
numbers in the reversed order. Cut-off scores were determined based on age and educational 
background. The maximum span that was achieved was noted. A higher span means a better 
performance. 
 
 In the trail making tests, a higher score means that the patients needed more time to complete 
the test. This indicates a worse performance. Cut-off scores were determined based on age 
and educational background.  
 
Other tests 
To assess behavioural and psychiatric disorders, the data from the NPI and GDS were used. 
The NPI is an heteroanamnestic interview to assess twelve behavioural aspects in which 
frequency and severity of every aspect is scored (Cronbach’s α= 0.62, sensitivity=64%, 
specificity=71% (Kat et al., 2002)). NPI does not have a cut-off score. Furthermore, the 15 
item GDS is used to detect depression in elderly. The GDS is a self-report survey (Cronbach’s 
α= 0.87, sensitivity=67% specificity=73% (Van Marrewijk et al., 1995)). A score of 10 points 
or higher indicates a mild depression, a score of 20 points or higher indicates severe 
depression.  
 
MRI procedure 
 
MRI was obtained on one of our 1.0T, 1.5T or 3T MR systems. An experienced 
neuroradiologist, blinded for patient’s complaints and medical history, reviewed all scans and 
performed visual ratings for all patients. A standardized protocol for rating brain atrophy and 
CVD on brain MRI scans was used (van der Flier et al., 2014). On fluid-attenuated inversion-
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recovery (FLAIR) sequences, white matter hyperintensities (WMH) were rated using the three 
point Fazekas scale: punctuate lesions (grade 1), beginning confluent lesions (grade 2) or 
confluent lesions (grade 3) (Fazekas, Chawluk, Alavi, Hurtig, & Zimmerman, 1987). Lacunes 
(deep lesions, 3-15 mm) were counted with low signal on T1-weighted sequences and high 
signal on T2-weighted sequences. Microbleeds were counted on T2* sequences and defined 
as small round hyperintense foci (till 10mm). CVD measures on MRI were clustered in white 
matter lesions (Fazekas score), lacunes, microbleeds, brain infarcts or brain haemorrhage. 
Lacunes and microbleeds were ditochomized in absent or 1 or more present. Measures for 
brain atrophy were not used in this study.  
 
Data analysis 
 
All statistical analyses were carried out using IBM SPSS 20 (Statistical Package for social 
Science) program for windows.  
 
For each patient the first cognitive symptoms were retrieved. These symptoms were divided 
based on the cognitive domain that is affected: memory, executive function, visuo-spatial, 
attention, change of behaviour, language, mixed symptoms and others (described previously 
in measures and procedures). The percentage of patients was calculated for each cluster. The 
number of patients for each domain were relatively low. To remain statistical power, patients 
were subdivided into larger clusters, i.e. memory, frontal dysfunction and a rest-category 
named ‘others’. This division is based on the results of previous studies that showed that 
memory problems and executive/frontal dysfunction are most common in VCI patients 
(Graham, Emery, & Hodges, 2014; Reed et al., 2007).  
 
Baseline characteristics for each cluster were retrieved (age, gender, educational level, 
diagnosis, NPI and GDS). Significance testing of the baseline characteristics was carried out 
using a multinominal logistic regression for dichotomous variables (gender, diagnosis) and an 
analysis of covariance (ANCOVA) for continuous variables (age, educational level, NPI and 
GDS). 
 
Next, univariate analyses of covariance (ANCOVA) were performed with the three groups; 
memory problems, frontal dysfunction and others, as between-subject factor and the separate 
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neuropsychological tests as within-subject factor. In all analysis GDS, NPI and diagnosis 
were used as a covariates.  
 
Next we generated domain scores for global cognition (MMSE), memory (VAT, RAVLT 
immediate recall and RAVLT delayed recall), attention (TMT-A and digit span forward), 
executive function (TMT-B and digit span backward) and language (VAT and letter fluency). 
These neuropsychological tests have different rating scales. Thus standardized Z-scores were 
generated using SPSS, according to the following formula: 
ó
µX
Z .  
TMT-A and TMT-B scores were inverted because only for TMT-A and TMT-B a higher 
score indicates a worse performance on the tests, whereas for the other tests a higher score 
indicated a better performance. Therefore, a -1*z-score had been computed for TMT-A and 
TMT-B. An ANCOVA was used with the three groups; memory problems, frontal 
dysfunction and others, as between-subject factor and the domain scores as within-subject 
factor. In all analysis GDS, NPI and diagnosis were used as covariates.  
 
Patients often have combinations of CVD, for example an infarct and several microbleeds. 
Therefore, the CVD measures were not investigated as a separate entity but instead, 
frequently occurring combinations of CVD were clustered. We undertook a classification 
using Two-Step clustering in SPSS. In total five variables were used to account for vascular 
damage (Fazekas, microbleeds, lacunes, infarct and haemorrhages). Subsequently, the 
individual subjects who belonging to a certain group were identified. Last, we tested 
statistically whether the clusters of individuals – based solely on CVD measures – differed 
with regard to clinical (i.e. first symptom) and neuropsychological features (NPO test scores).  
For all analyses, the significance level was set at p<0.05. 
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Results 
 
We expected that the most prominent first cognitive symptoms at baseline would be memory 
problems and executive dysfunction. The first cognitive symptoms of VCI patients at their 
first visit in our memory clinic can be seen in figure 1. Memory problems are most prominent 
(89 patients), followed by change of behaviour (22 patients). 14 patients mentioned problems 
in attention as most prominent symptom, 13 patients mentioned problems in mental speed, 10 
patients mentioned problems in executive functioning, another 10 patients mentioned 
problems in visuo-spatial functioning and another 10 patients mentioned problems in 
language. 13 patients reported other most prominent cognitive symptoms (hallucinations, 
depression, apathy and physical symptoms) than the ones previously noted.  
 
 
 
 
Most prominent cogntive symptoms in VaD and vaMCI patients at their first 
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Fig. 1. Most prominent cognitive symptoms in VCI patients at their first visit.  
 
 
In order to maintain statistical power larger groups were made. The group of memory 
problems remains unchanged. Patients with problems in executive functioning, attention and 
change of behavior were taken together to form the group ‘frontal dysfunction’ (n=46). 
Patients with problems in visuo-spatial functioning, mental speed and language were included 
in the already existing group ‘others’.  
Table 1 lists the baseline characteristics. In patients with memory complaints, age (mean ± 
SD) was 70 ± 8 years and 32 patients (36%) were female. In patients with frontal dysfunction, 
age was 68 ± 7 and 13 (28%) were female. In patients with other symptoms, age was 71 ± 8 
and 21 (46%) were female. The groups differed in NPI score (F=6.624, p=0.002) and in 
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percentage of VaD patients (χ2=10.264, p=0.006). There were no differences between the 
groups in gender, age, level of education and Geriatric depression scale score (Table 1).  
 
 
Table 1 
Baseline characteristics of VCI patients 
 Memory  
Frontal 
dysfunction  Others     
  n     n     n     F/χ2   p-value 
Sex (female), n (%) 89 32 (36%)  46 13 (28%)  46 21 (46%)  χ2=3.027  0.220 
Age (years) 89 70±8  46 68±7  46 71±8  F=2.320  0.101 
Level of education 
#
 72 5±1  39 5±1  41 5±1  F=0.481  0.619 
Diagnosis (VaD), n (%) 89 37 (42%)  46 30 (65%)  46 30 (65%)  χ2=10.264  0.006 
Geriatric depression scale 74 3±3  36 4±3  30 4±4  F=1.590  0.208 
Neuropsychiatric Inventory 55 9±9   29 19±15   31 15±15  F=6.624   0.002 
Number of patients (%) or means±SD are reported. Values are presented as mean ± standard deviation. ANOVA was  
conducted with age, education, GDS and NPI. Multinominal logistic regression was used when appropriate with memory as  
reference group. 
# according to the Verhage system (1-7) (Verhage, 1964) 
 
 
 
An ANCOVA was  performed for the MMSE, VAT, digit span test forward and backward, 
TMT-A, TMT-B, letter fluency and RAVLT immediate and delayed recall. In all analysis 
GDS, NPI and diagnosis were used as a covariate. Normality of the variables, homogeneity of 
variance using Levene’s test and homogeneity of covariance were checked. Assumptions for 
ANCOVA were met (independence, normality and homogeneity of the residuals).  
 
Dementia severity and global cognitive decline, as measured by MMSE, did not differ 
between patients with memory problems, frontal dysfunction or other symptoms (Table 2). 
No differences on VAT were found. Patients did differ in performance on the immediate and 
delayed recall of the Dutch RAVLT. For immediate recall as well as the delayed recall of the 
Dutch RAVLT, patients with other symptoms had the lowest score and patients with frontal 
dysfunction the highest. The significance was determined by this difference between patients 
with other symptoms and frontal dysfunction. Furthermore, patients differed in letter fluency 
performance: patients with other symptoms had the lowest scores. No differences were found 
in performance on TMT-B, Digit Span backward, TMT-A and Digit Span forward.  
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Table 2 
Neuropsychological test performance of VCI patients 
 Memory  
Frontal 
dysfunction  Others     
  n*     n*     n*     F   p-value 
Global cognition             
MMSE 55 25,4±3,2  29 25,1±4,1  31 24,2±3,7  1.518  0.224 
Memory             
VAT 55 4.8±1.5  29 5.0±1,4  31 4,6±1,4  1.049  0.354 
RAVLT¥, total immediate recall 49 28,8±8,9  24 32,8±9,3  25 27,5±7,8  4.270  0.017 
RAVLT¥, delayed recall 49 3,9±3,1  24 6,4±3,5  25 3,6±2,6  7.685  0.001 
Language             
VAT 55 4.8±1.5  29 5.0±1,4  31 4,6±1,4  1.049  0.354 
Letter fluency 38 24,7±9,9  23 25,4±10,1  21 17,7±8,5  4.672  0.012 
Executive functioning             
TMT-B
§
 45 189,3±152  21 224,4±144  20 239,5±105  0.165  0.848 
Digit Span backward 59 7,1±2,1  29 6,5±2,6  29 5,9±2,3  1.654  0.196 
Attention             
TMT-A
§
 55 70,2±51,8  25 71,5±49,3  30 96,7±75,6  1.601  0.207 
Digit Span forward 55 11,3±3,0  29 10.0±2,4  29 10.0±2.7   1.674   0.192 
Performance on neuropsychological tests are presented as mean ± standard deviation. Cognitive profiles are divided  
into neuropsychological tests. Univariate analyses of variance were performed with first symptom as between-subject 
factor. GDS and NPI were entered as covariates. 
* patients dropped out due to missing values on the covariate NPI.  
¥Dutch version of the Rey Auditory Verbal Learning Task (RAVLT). 
§Higher scores imply worse performance. 
 
 
Figure 2 shows the performance of patients with memory problems, frontal dysfunction and 
other symptoms on five cognitive domains: global cognition, memory, attention, executive 
function, and language. Patients differed in mean z-score on the domains of memory and 
language. Patients with memory problems scored best on attention and executive functioning. 
Patients with frontal dysfunction scored best on the memory and language domain. Patients 
with other symptoms had the lowest score on all domains.  
 
Next, we performed a cluster analysis with CVD measures. Two-Step cluster analysis 
revealed four groups of patients (figure 3).  
 
Group 1 
This group contains 22.2% of the patients (n=39). This group was characterised by the 
absence of brain infarcts and brain haemorrhages.  
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Fig. 2. Mean neuropsychological Z-scores by memory, frontal dysfunction and other first symptoms in 
VaD and vaMCI patients. The x-axis shows the five cognitive domains: global cognitive functioning, 
memory, attention, executive function and language. The y-axis shows the mean z-scores. Univariate 
analyses of variance were performed with GDS and NPI as covariates. * indicates a significant 
difference. 
A negative score indicates a worse performance. 
 
Fazekas 1 was the most frequent Fazekas score in this group, indicating mild white matter 
lesions. Furthermore, lacunes were found in this group. None of the patients had microbleeds. 
 
Group 2 
This group contains 27.8% of the patients (n=49). This group was characterised by the 
absence of brain infarct and the presence of brain hemorrhage was low. Fazekas 3 was the 
most frequent Fazekas score, indicating severe white matter lesions. Furthermore, a high 
percentage of lacune and microbleeds were found.  
  
Group 3 
This group contains 28.4% of the patients (n=50). This group was characterised by brain 
infarct. Furthermore, lacunes, microbleeds and haemorrhages are present in this group. 
Fazekas 0 was the most frequent Fazekas score, indicating no white matter lesions. However, 
Fazekas 3 was also evident, indicating severe white matter lesions.  
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Group 4 
This group contains 21.6% of the patients (n=38). This group was characterised by the 
absence of microbleeds, lacunes, haemorrhages and a low percentage of brain infarct. 
However, Fazekas 2 and 3 are frequent in group 4, indicating moderate to severe white matter 
lesions. This group contains patients with predominantly white matter lesions.  
 
 
 
 
 
Fig. 3. Distribution of patients over the four clusters and their CVD scores. The grey bars represent the 
total number of patients with a positive score on each CVD measure in the whole study sample. The 
coloured balks represent the number of patients with a positive score on each CVD measure within the 
cluster groups.  
 
With this cluster analysis, subjects belonging to the four determined clusters were identified. 
This allows to determine the cognitive characteristics of the four groups. These characteristics 
together with the demographic characteristics can be found in table 3. No significant 
differences were found in demographic characteristics, except for sex; group 4 contains of 
more females compared with the other groups.  
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Table 3 
Demographic characteristics of the four groups of patients detected by cluster analysis 
 Group 1  Group 2  Group 3   Group 4     
  n     n     n     n     F/χ2   p-value 
Baseline characteristics                
number of women, n (%) 39 13(33%)  49 13(27%)  50 16(32%)  38 22(58%)  χ2=9.970  0.019 
Age in years 39 68 (9)  49 68 (6)  50 71 (7)  38 71 (8)  F=1.669  0.176 
Level of education 
#
 35 4(2)  42 5 (1)  39 5 (1)  33 5 (1)  F=2.056  0.109 
number of VaD patients, n (%) 39 17(44%)  49 25(51%)  50 32(64%)  38 18(47%)  χ2=4.378  0.223 
Geriatric depression scale 32 3 (3)  38 4 (4)  38 4 (3)  30 3 (3)  F=1.390  0.249 
Neuropsychiatric Inventory 22 10 (10)  33 15 (12)  33 15 (16)  27 12 (11)  F=1.038  0.379 
Demographic characteristics are presented as mean (standard deviation). 
Univariate analyses of variance were performed with first symptom as between-subject factor. Multinominal logistic regression 
was used when appropriate with memory as reference group.  
# according to the Verhage system (1-7) (Verhage, 1964) 
 
The groups differed in score on the immediate and delayed recall of the Dutch RAVLT. For 
both the immediate and the delayed recall, group 3 had the lowest scores and group 4 the 
highest.  
 
Table 4 
Neuropsychological performance of the four groups of patients detected by cluster analysis 
 Group 1  Group 2  Group 3   Group 4     
  n     n     n     n     F/χ2   p-value 
Neuropsychological tests                
Global cognition                
MMSE 39 25 (3)  49 25 (4)  50 24 (4)  38 25 (3)  F=0.966  0.410 
Memory                
VAT 39 5 (2)  49 5 (1)  50 5 (2)  38 5 (2)  F=1.211  0.307 
RAVLT*, total immediate recall 29 28 (8)  42 30 (11)  37 26 (8)  28 32 (9)  F=2.636  0.050 
RAVLT*, delayed recall 29 4 (3)  42 5 (3)  37 3 (2)  28 5 (3)  F=2.871  0.039 
Language                
VAT 39 5 (2)  49 5 (1)  50 5 (2)  38 5 (2)  F=1.211  0.307 
Letter fluency 20 23 (10)  36 23 (11)  30 20 (9)  25 24 (12)  F=0.714  0.546 
Executive functioning                
TMT-B
§
 31 184 (91)  33 190 (110)  33 243 (160)  28 215 (147)  F=1.399  0.246 
Digit Span backward 38 6 (2)  49 7 (2)  47 6 (2)  37 6 (2)  F=0.397  0.756 
Attention                
TMT-A
§
 39 81 (70)  44 73 (34)  47 101 (81)  37 75 (51)  F=1.850  0.140 
Digit Span forward 38 10 (3)   49 11(2)   47 10 (3)   37 10 (3)   F=1.029   0.381 
Performance on neuropsychological tests are presented as mean ± standard deviation. Cognitive  
profiles are divided into neuropsychological tests. Univariate analyses of variance were performed with first symptom as  
between-subject factor. 
∗Dutch version of the Rey auditory verbal learning task (RAVLT). 
§Higher scores imply worse performance. 
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 No other differences were found in the neuropsychological tests. No differences in first 
symptom could be found (table 5).  
 
Table 5 
First symptoms of the four groups detected by cluster analysis 
  
Group 1 
 
Group 2 
 
Group 3 
 
Group 4 
                        χ2   p-value 
First symptom 
         
3.524 
 
0.741 
memory 
 
22 (56%) 
 
19 (39%) 
 
25 (50%) 
 
19 (50%) 
    frontal dysfunction 
 
9 (23%) 
 
16 (32%) 
 
11 (22%) 
 
10 (26%) 
    others   8 (20%)   14 (28%)   14 (28%)   9 (24%)         
First symptoms are presented as number (percentage) 
Statistical analysis was performed using multinominal logistic regression. 
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Discussion 
 
In this study we aimed to investigate what the most frequent first symptoms of VCI patients 
are and whether we could objectify these findings on neuropsychological assessment. Since 
brain imaging is an important aspect of the diagnostic procedure and CVD measures often 
occur in combination with each other, we also aimed to study frequent combinations of CVD 
in VCI patients. Finally, we investigated  the contribution of these CVD combinations on 
cognition. 
 
Main findings 
 
Consistent with our hypothesis memory problems were the most frequent symptom in our 
sample of VCI patients at their first visit in our memory clinic. Other studies revealed that 
VCI patients show deficits in executive and attentional abilities (Graham, Emery, & Hodges, 
2014). However, executive dysfunction was not a predominant symptom in our study. Instead, 
the second most frequent symptom found was change in behaviour. This can be explained in 
several ways. An influential model of how cognitive dysfunction is caused by CVD posits that 
damage to frontostriatal loops causes impairment in frontal lobe functioning. Moreover, 
cholinergic projections to the frontal lobe are especially vulnerable for white matter damage 
(Selden et al., 1998). This then leads to predominant executive function deficits. Secondary to 
executive dysfunction are impairments of associated cognitive functions such as memory 
(Reed et al., 2007). It is therefore possible that we underestimated the number of patients with 
predominantly executive problems. Since changes in behaviour result from frontal damage or 
damage to frontal projections, our finding that the second most frequent cognitive symptom in 
VCI patients are changes in behaviour can be supported by the hypothesis of Reed et al. 
(2007) as well.  
 
Another possibility is that patients are unaware of their problems or unable to explain their 
problems appropriately. Studies investigating the symptom awareness of patients with mild  
cognitive impairment (MCI) or Alzheimer’s disease show in general an impaired awareness 
of their symptoms (Vogel et al., 2004). This impaired awareness can result in a less accurate 
reportage of symptoms. Furthermore, executive dysfunction is already a difficult concept for 
professionals in the field of neuroscience. There is a general agreement that executive 
function refers to ‘higher-level’ processes or mental control processes. However some include 
also attentional processes and/or inhibitory processes. Therefore, it is not surprising that 
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patients have difficulties in identifying executive problems. This again may have led to an 
underestimation of executive dysfunction (Alvarez, & Emory, 2006).  
 
We were able to objectify that patients in the frontal group (consisting of self reported 
executive problems, attention deficits and behavioural changes) perform better on tests for 
memory compared with patients with mainly memory complaints. However, the performance 
is not significantly better. We expected to find a significant difference in performance in both 
groups, but it seems that patients in the specific groups have not such a specific pattern on 
neuropsychological assessment. This is probably due to the diversity of our frontal group.  
 
Interestingly, although only significant in memory and language, VCI patients with other 
cognitive problems had the lowest score in all cognitive domains. The low scores on tests for 
language were expected, as a substantial number of the patients with other problems had 
language problems resulting in the lower scores on the other cognitive domains. Known from 
earlier research, language production may also be impaired in VCI patients, which is 
consistent with our findings (Weintraub, Wicklund, & Salmon, 2012). Furthermore, another 
substantial number of patients with ‘other’ symptoms had impaired mental speed, which also 
reduces the scores on all tests and especially on tasks time-bound.  
 
Cluster analysis of CVD revealed 4 groups of combined CVD measures. One consisted of all 
patients who suffered from a brain infarct (group 3) and had a high amount  of additional 
cerebrovascular disease (lacunes and microbleeds) while white matter lesions were less 
prominent. Even though the amount of severe white matter lesions was low,  taken together 
this group contained patients with a high level of CVD. We therefore labelled this group with 
most combined CVD as the most severe CVD group. As hypothesized patients in the cluster 
with the most severe CVD, group 3,  had the lowest scores on all cognitive domains 
indicating that they were more impaired in cognition. However, we expected to find mainly 
impairment on non-memory related domains because most studies indicate that severe CVD is 
related with non-memory-related dysfunction (Graham, Emery, & Hodges, 2014; Reed et al., 
2007). In contrast to this previous study, patients in our severe CVD group were significantly 
more impaired on tests for memory (immediate and delayed recall of the RAVLT) and there 
were no significant differences on non-memory domains.  
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In the study of Graham, Emery and Hodges (2014) and in the study of Reed et al. (2007) 
CVD severity was measured only by  WMHs. In our study, patients with a high level of CVD 
had a surprisingly little WMHs and almost all patients suffered from brain infarction. This 
difference in type of CVD could be an explanation for our non-significant differences in non-
memory related domains. Moreover, the location of the brain infarcts were not known in our 
study. Infarcts in certain areas might have  influenced memory.  
 
On the other hand, while most studies indicate that severe CVD is related with impairment in 
non-memory-related functions, some studies found that also immediate and delayed memory 
and verbal learning are impaired (Graham, Emery, & Hodges, 2014; Kim, Kim, Kim, & 
Chang, 2014; Reed et al., 2007). In the study of Kim, Kim, Kim and Chang (2014), patients 
had mainly stroke (infarct and haemorrhages) just like our severe CVD group. This then is 
compatible with our results. Results of previous studies only partially match our results. This 
is probably caused by the broader definition of CVD in our study for we chosen to incorporate 
not only one type of CVD but also combinations.  
 
Remarkably, patients with only severe WMHs (group 4) had a good neuropsychological tests 
performance compared with the other groups. This suggests that white matter lesions alone, 
may be less impairing as expected. WMHs have been associated with cognitive dysfunction, 
although not on a specific domain (de Groot et al., 2000). In the study of Brickman et al. 
(2009), they concluded that one should not focus on WHMs alone. They found that both brain 
reserve and cognitive reserve appeared to moderate the impact of WMHs on cognition 
(Brinkman et al., 2009). However, brain injury such as WMHs also occur in normal aging so 
it seems like the dysfunction is partly due to the WMHs (Maillard et al., 2012). Brain infarct, 
on the other hand, was predominant in group 3 and may be more impairing. In literature, brain 
infarct has been found to affect cognitive functioning and is a major risk factor for developing 
vascular dementia which is also shown in our finding (O’Brien et al. 2003; Rincon, & Wright, 
2013).  
 
Limitations and Strengths 
 
There are some potential limitations in our study. Due to the use of a retrospective cross-
sectional study design, it is difficult to draw firm conclusions. The database of the Amsterdam 
Dementia Cohort is a rich source of data however during our study we discovered that the test 
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results for neuropsychological tests were recorded inconsistent which led to the exclusion of 
patients. Moreover, no specific tests for praxis, gnosis and visuo-spatial function were 
included in our neuropsychological assessment.  
 
Another limitation is that we did not compare our results to healthy subjects at this moment. 
We can carefully suggest that it is to be expected that our patient population performed worse 
than healthy controls, but  this is not supported by data analyses. It would have been 
especially interesting to see whether patients performing best on NPO did perform below or 
on the same level as healthy controls. However, several studies state that VCI patients are 
significantly more impaired on global cognition, executive dysfunction and memory 
compared to patients with subjective memory complaints (O’Brien et al., 2003; Smits et al., 
2014; Young Lee, 2011), therefore we assume even in the best performing patients a 
suboptimal performance. 
 
Furthermore, we did not have a separate group of ‘executive dysfunction’. Due to small 
sample size, we included patients with executive dysfunction in a group of ‘frontal 
dysfunction’. The frontal lobes are not exclusively involved in executive functioning but are 
directly and indirectly involved in a wide spectrum of human thought, behavior and emotion 
(Alvarez, & Emory, 2006). In our study, the group of frontal dysfunction not only consisted of 
patients with executive problems, but also of patients with problems in attention and changes 
in behavior including apathy. Most studies did not combined change of behavior and 
executive dysfunction in one group ( O’Brien et al., 2003; Smits et al., 2014; Young Lee, 
2011). In our study, we might have underestimated the effect of executive dysfunction and we 
have to be careful with statements about our results in relation to literature. 
 
Among the strengths of this study are the fact that we investigated the three most important 
aspects of the diagnostic criteria in VCI patients; i.e. clinical presentation (symptoms), 
neuropsychological test performance and CVD measures. Also, we had a large cohort of VCI 
patients and the availability of a standardized neuropsychological test battery. Furthermore, 
the diagnosis of VCI (probable or possible VaD or vaMCI) was made in a multidisciplinary 
meeting by physicians who regularly practice the diagnostic criteria of NINDS-AIREN and 
NIA-AA. The MRI scans were evaluated by professional neuroscientists and 
neuroradiologists, EEG’s were made and a broad neuropsychological test battery was used. 
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All tests are administered by professionals to make a sound diagnosis (van der Flier et al., 
2014).  
 
Furthermore, we used at least two tests for each investigated cognitive domain. Studies 
indicate that test performance can differ within each domain (Huppert, & Tym, 1986). 
Because we used at least two tests for each domain, were able to make a more reliable domain 
score. Another strength of our study is the acknowledging of microbleeds on MRI. In most 
studies, microbleeds are not taken into account while recent research reveals their importance 
in vascular dementia (Arauz, 2013; Van der Flier & Cordonnier, 2012). Using these 
microbleeds in combination with the other known vascular MRI abnormalities (white matter 
hyperintensities, lacunes, infarct, haemorrhages), we were able to make a rather complete 
representation of CVD on MRI. 
 
Implications 
Our study has important clinical implications. First, it supports the clinical observation that 
VCI patients form a heterogeneous group considering their symptoms, their CVD and 
combinations of types of this CVD.  
Second, to our knowledge this is the first study investigating differences on 
neuropsychological test performance within a large group of VCI patients. Several studies 
revealed a distinct neuropsychological profile for VCI patients as a whole compared to other 
types of dementia (Graham, Emery, & Hodge, 2004; Reed et al., 2007; Smits et al., 2014), but 
our study shows that within the group of VCI patients differences in neuropsychological 
performance also can be found. This could lead to a further differentiation of VCI patients and 
might be used to develop a tool  in clinical practice for early detection an appropriate 
intervention. However, our data should be supported by more data and to do so further 
research into neuropsychological profiles in VCI patients is needed.   
In our study we found that patients with severe CVD had the worst performance on 
neuropsychological tests. These patients might experience the most impairment in daily 
living. Currently there is no cure for VCI, nor a symptomatic treatment. Both the dementia 
syndrome and CVD are progressive over time. Many CVD risk factors such as hypertension, 
overweight, diabetes mellitus, smoking, and alcohol intake are modifiable. To identify these 
patients at an early stage is of great clinical importance since at earlier stage the CVD is less 
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severe and life style changes can be made in an attempt to prevent the CVD to progress 
rapidly. As a result this might slow down (or ultimately prevent) the progression towards 
dementia (Kling, Trojanowski, Wolk, Lee, & Arnold, 2013).  
 
Conclusion 
 
This study indicates that within the group of VCI patients, different neuropsychological 
profiles exist. Future research is necessary to investigate the distinct neuropsychological 
profiles within the group of VCI patients for further differentiation of VCI patients to aim at 
early detection of these patients. In our study the number of ‘pure’ executive dysfunction was 
relatively low resulting in a mixed frontal dysfunction group. Since literature states that 
executive dysfunctioning is one of the most prominent symptoms in VCI patients (Reed et al., 
2007), it would be interesting for a future study to select a larger group of patients with 
mainly executive dysfunctioning and investigate them as a separate entity. These different 
neuropsychological profiles should be further investigated to define specific 
neuropsychological profiles within VCI patients which could help in early detect of these 
patient and appropriate intervention. 
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List of abbreviations  
AD: Alzheimer’s disease 
ANCOVA: analysis of covariance 
CVD: Cerebrovascular disease 
EEG: Electroencephalogram 
FLAIR: fluid-attenuated inversion-recovery 
GDS: Geriatric Depression Scale 
MCI: mild cognitive impairment 
MID: multiinfarct dementia 
MMSE: mini mental state examination 
MRI: magnetic resonance imaging  
NIA-AA: National Institute on Aging-Alzheimer’s Association 
NINDS-AIREN: National Insititute of Neurological Disorders and Stroke and Association Internationale  
pour la Recherché et l’Enseignement en Neuroscience 
NPI: Neuropsychiatric Inventory 
NPO: neuropsychological investigation 
RAVLT: Rey Auditory Verbal Learning Task 
SPSS: Statistical Package for social Science 
TMT: Trail making task 
VaD: Vascular dementia 
vaMCI: vascular mild cognitive impairment 
VAT: Visual Association Test 
VCI: vascular cognitive impairment 
VUmc: VU University medical center 
WMH: White matter hyperintensities 
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Appendices 
Appendix I NINDS-AIREN criteria for vascular dementia 
I. The criteria for the clinical diagnosis of probable vascular dementia include all of the following: 
1. Dementia defined by cognitive decline from a previously higher level of functioning and 
manifested by impairment of memory and of two or more cognitive domains (orientation, 
attention, language, visuospatial functions, executive functions, motor control, and praxis), 
preferable established by clinical examination and documented by neuropsychological testing; 
deficits should be severe enough to interfere with activities of daily living not due to physical 
effects of stroke alone. 
Exclusion criteria: cases with disturbance of consciousness, delirium, psychosis, severe 
aphasia, or major sensorimotor impairment precluding neuropsychological testing. Also 
excluded are systemic disorders or other brain diseases (such as AD) that in and of 
themselves could account for deficits in memory and cognition. 
2. Cerebrovascular disease, defined by the presence of focal signs on neurologic examination, 
such as hemiparesis, lower facial weakness, Babinski sign, sensory deficit, hemianopia, and 
dysarthria consistent with stroke (with or without history of stroke), and evidence of nof 
relevant CVD by brain imaging (CT or MRI) including multiple large vessel infarcts or a single 
strategically placed infarct (angular gyrus, thalamus, basal forebrain, or PCA or ACA 
territories), as well as multiple basal ganglia and white matter lacunes, or extensive 
periventricular white matter lesions, or combinations thereof. 
3. A relationship between the above two disorders, manifested or inferred by the presence of one 
or more of the following: (a) onset of dementia within 3 months following a recognized stroke; 
(b) abrupt deterioration in cognitive functions; or fluctuating, stepwise progression of cognitive 
deficits. 
II. Clinical features consistent with the diagnosis of probable vascular dementia include the following: 
(a) Early presence of gait disturbance (small-step gait or marche a petits pas, or magnetic, apraxic-
ataxic or parkinsonian gait); (b) history of unsteadiness and frequent, unprovoked falls; (c) early 
urinary frequency, urgency, and other urinary symptoms not explained by urologic disease; (d) 
pseudobulbar palsy; and (e) personality and mood changes, abulia, depression, emotional 
incontinence, or other subcortical deficits including psychomotor retardation and abnormal executive 
function. 
III. Features that make the diagnosis of vascular dementia uncertain or unlikely include (a) early onset 
of memory deficit and progressive worsening of memory deficit and progressive worsening of memory 
and other cognitive functions such as language (transcortical sensory aphasia), motor skills (apraxia), 
and perception (agnosia), in the absence of corresponding focal lesions on brain imaging; (b) absence 
of focal neurological signs, other than cognitive disturbance; and (c) absence of cerebrovascular 
lesions on brain CT or MRI. 
IV. Clinical diagnosis of possible vascular dementia may be made in the presence of dementia 
(section I-1) with focal neurologic signs in patients in whom brain imaging studies to confirm definite 
CVD are missing; or in the absence of clear temporal relationship between dementia and stroke; or in 
patients with subtle onset and variable course (plateau or improvement) of cognitive deficits and 
evidence of relevant CVD. 
V. Criteria for diagnosis of definite vascular dementia are (a) clinical criteria for probable vascular 
dementia; (b) histopathologic evidence of CVD obtained from biopsy or autopsy; (c) absence of 
neurofibrillary tangles and neuritic plaques exceeding those expected for age; and (d) absence of 
other clinical or pathological disorder capable of producing dementia. 
VI. Classification of vascular dementia for research purposes may be made on the basis of clinical, 
radiologic, and neuropathologic features, for subcategories or defined conditions such as cortical 
vascular dementia, subcortical vascular dementia, BD, and thalamic dementia. 
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The term “AD with CVD” should be reserved to classify patients fulfilling the clinical criteria for possible 
AD and who also present clinical or brain imaging evidence of relevant CVD. Traditionally, these 
patients have been included with VaD in epidemiologic studies. The term “mixed dementia,” used 
hitherto, should be avoided. 
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Appendix II NIA-AA criteria for MCI 
Clinical characteristics 
I. concern regarding a change in cognition – There should be evidence of concern about a 
change in cognition, in comparison with the person’s previous level. This concern can be 
obtained from the patient, from an informant who knows the patient well, or from a skilled 
clinician observing the patient.  
II. Impairment in one or more cognitive domains – There should be evidence of lower 
performance in one or more cognitive domains that is greater than would be expected for 
the patient’s age and educational background.  
III. Preservation of independence in functional abilities – persons with MCI commonly have 
mild problems performing complex functional tasks which they used to perform previously. 
They may take more time, be less efficient, and make more errors at performing such 
activities than in the past. Nevertheless, they generally maintain their independence of 
function in daily life, with minimal aids or assistance.  
IV. Not demented – These cognitive changes should be sufficiently mild that there is no 
evidence of a significant impairment in social or occupational functioning. It should be 
emphasized that the diagnosis of MCI requires evidence of intraindividual change.  
Cognitive characteristics 
It is important to determine whether there is objective evidence of cognitive decline, and if so, the 
degree of this decline in the reports by the individual and/or an informant. Scores on cognitive tests for 
individuals with MCI are typically 1 to 1.5 standard deviation below the mean for their age and 
education matched peers on culturally appropriate normative data.  
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Appendix III informed consent 
 
 
Onderzoek naar de diagnostiek van dementie 
 
 
Als Alzheimercentrum VUmc willen wij ons steentje bijdragen aan het wetenschappelijk onderzoek 
naar de ziekte van Alzheimer, in de hoop dichter bij een effectieve therapie te komen.  
 
Wij hopen dat u geen bezwaar heeft als wij uw gegevens gebruiken voor wetenschappelijk onderzoek. 
Uiteraard heeft dit geen enkele consequentie voor uw behandeling in het Alzheimercentrum. Tevens 
nemen wij in de toekomst mogelijk contact op met uw huisarts om op de hoogte te blijven van de 
progressie van uw aandoening. Op dit formulier kunt u uw mening hieromtrent kenbaar maken.  
 
Ik geef hierbij toestemming voor het gebruik van mijn gegevens voor wetenschappelijke doeleinden. Ik 
realiseer mij dat deze keus geen enkele invloed heeft op de behandeling. 
 
 
Achternaam en voorletters : ………………………………………………… 
Geboortedatum:   ………………………………………………… 
Handtekening:   ………………………………………………… 
 
Partner/ familielid  
Achternaam en voorletters : ………………………………………………… 
Relatie tot deelnemer:  ………………………………………………… 
Handtekening:   ………………………………………………… 
 
 
Naam onderzoeker              …………………………………………………. 
   
Handtekening onderzoeker    …………………………………………………. 
 
Datum                                   …………………………………………………. 
 
 
